US Stocks
/
GeoVax Labs, Inc. Share Price
GeoVax Labs, Inc. Share Price

GeoVax Labs, Inc. Share Price

NASDAQ: GOVX | Micro Cap
$0.29
+$0.00 (0.24%) Last updated on 09 Oct, 2026 | 21:24 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

GeoVax Labs, Inc. Stock Performance

Open
$0.28
Prev. Close
$0.29
Circuit Range
N/A
Day Range
$0.28 - $0.28
Year Range
$0.12 - $4.36
Volume
4,200
Average Traded
$0.28

GeoVax Labs, Inc. Share Price Today

As of 9 October 2026, GeoVax Labs, Inc.'s share price is $0.29. The stock opened at $0.28, compared to its previous close of $0.29. During today's trading session, GeoVax Labs, Inc.'s share price traded between $0.28 and $0.28, with an average price of $0.28. Over the past 52 weeks, the stock has recorded a high of $4.36 and a low of $0.12. In terms of performance, GeoVax Labs, Inc.'s share price has declined by 70.71% over the last six months and is down 48.03% on a year-on-year basis.

GeoVax Labs, Inc. Share Price Chart

$0.28$0.28
L
Show Current Price
H

GeoVax Labs, Inc. Stock Fundamentals & Key Indicators

Market Cap
$275935.74
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.25
Revenue (TTM)
$2.49B
Return On Equity (TTM)
-1160.10%
Profit Margin
-861.85%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
29.91%

GeoVax Labs, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.32-$4.42-$5.26-$4.43
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A30.06%-19.00%15.78%

GeoVax Labs, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.08$0.00$3.95$2.49
Net Profit-$14.02-$25.97-$24.99-$21.46
Net Profit Margin-17525.00%N/A-632.66%-861.85%
Income ChangeN/A-85.24%3.77%14.13%

About GeoVax Labs, Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

GeoVax Labs, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.33
$0.29
-16.81%
Sep 2026
$0.60
$0.34
-53.50%
Aug 2026
$0.73
$0.74
+4.07%
Jul 2026
$1.27
$0.71
-42.96%
Jun 2026
$2.27
$1.25
-40.76%
May 2026
$1.14
$2.11
+114.65%
Apr 2026
$1.39
$0.98
-26.09%
Mar 2026
$1.60
$1.33
-17.90%
Feb 2026
$2.74
$1.62
-42.04%
Jan 2026
$0.18
$2.79
+1,497.14%
Dec 2025
$0.41
$0.17
-57.42%
Nov 2025
$0.56
$0.41
-25.81%

GOVX Share Price FAQs

What is GeoVax Labs, Inc. share price today?

chevron-up
GeoVax Labs, Inc. share price today is $0.29 as on October 9, 2026 at 9:24 pm IST.

What is the 52 week high and 52 week low of GeoVax Labs, Inc. stock?

chevron-up
The 52 week high of GeoVax Labs, Inc. stock is $4.36, while the 52 week low is $0.12 as of 9 Oct '26.

What is GOVX's market capitalisation today?

chevron-up
GOVX market capitalisation is $275935.74 as of October 9, 2026, at 10:17 pm IST.

What is GOVX's net income for the last quarter?

chevron-up
GOVX's net income for the last quarter is -4.43B USD.

What is the 5 year returns of GOVX?

chevron-up
The 5 year returns of GOVX is -99.54% as on 9 Oct '26.

What is the high & low stock price of GOVX today?

chevron-up
GOVX stock price hit a high of $0.28 and low of $0.28 as of 9 Oct '26.

Can I buy GOVX shares in India?

chevron-up
Yes. You can buy GOVX in India by opening an international trading account.